GT Biopharma Inc (GTBP)
3.12
-0.15
(-4.59%)
USD |
NASDAQ |
May 17, 16:00
3.83
+0.71
(+22.76%)
After-Hours: 20:00
GT Biopharma Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
June 30, 2015 | 4.402M |
March 31, 2015 | 3.758M |
December 31, 2014 | 3.359M |
September 30, 2014 | 3.012M |
June 30, 2014 | 2.824M |
March 31, 2014 | 2.725M |
December 31, 2013 | 2.588M |
September 30, 2013 | 2.27M |
June 30, 2013 | 2.167M |
March 31, 2013 | 1.925M |
December 31, 2012 | 1.88M |
September 30, 2012 | 2.68M |
June 30, 2012 | 2.205M |
March 31, 2012 | 2.20M |
December 31, 2011 | 2.061M |
September 30, 2011 | 0.198M |
June 30, 2011 | 2.094M |
March 31, 2011 | 2.038M |
December 31, 2010 | 2.164M |
September 30, 2010 | 2.173M |
June 30, 2010 | 2.336M |
March 31, 2010 | 2.602M |
December 31, 2009 | 2.374M |
September 30, 2009 | 2.294M |
June 30, 2009 | 2.195M |
Date | Value |
---|---|
March 31, 2009 | 2.158M |
December 31, 2008 | 2.148M |
September 30, 2008 | 2.143M |
June 30, 2008 | 1.074M |
March 31, 2008 | 0.966M |
December 31, 2007 | 0.00 |
September 30, 2007 | 0.628M |
June 30, 2007 | 0.458M |
March 31, 2007 | 0.29M |
December 31, 2006 | 3.184M |
September 30, 2006 | 3.545M |
June 30, 2006 | 3.66M |
March 31, 2006 | 3.66M |
December 31, 2005 | 3.06M |
September 30, 2005 | 0.00 |
June 30, 2005 | 0.00 |
March 31, 2005 | 0.16M |
December 31, 2004 | 1.36M |
September 30, 2004 | 1.764M |
June 30, 2004 | 1.621M |
March 31, 2004 | 0.279M |
December 31, 2003 | 0.16M |
September 30, 2003 | 0.16M |
June 30, 2003 | 0.16M |
March 31, 2003 | 0.16M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
Cutera Inc | 419.27M |
Outlook Therapeutics Inc | -- |
180 Life Sciences Corp | -- |
Journey Medical Corp | 14.68M |
NovaBay Pharmaceuticals Inc | 1.007M |